The EC approval is based on results from the Phase III EMPEROR-Preserved trial of 10mg empagliflozin versus placebo.
Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China.
Results showed a clinically meaningful prevention of bleeds in people with severe haemophilia A
AbbVie announced that it has resolved all U.S. HUMIRA (adalimumab) litigation with Alvotech.
In 2012, Moti Shniberg sold his face recognition startup to Facebook and started looking for a new challenge.
The WHO updated its guidelines to recommend molnupiravir, Merck’s antiviral pill, for treating patients newly diagnosed with Covid-19.
Back in summer 2020, Gilead acquired Immunomedics for $21 billion hoping to turn its breast cancer drug Trodelvy into a megablockbuster.
A new Australian DNA test could rewrite the book on disease diagnosis.
The FDA has denied Ocugen’s Emergency Use Authorization (EUA) request for use of its COVID-19 vaccine in children aged two to 18 years.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.
